BR1DGE Webinar Series - Advancing T1D Care: Teplizumab in Practice

This webinar is part of the Translating Global Insights into Canadian T1D Screening Practice 2-Part Webinar Series.

Explore teplizumab and emerging approaches in T1D care.

Another session in this series, T1D Screening: From Evidence to Practice, will take place on Thursday, November 26, 2026. Registration for this session will automatically register you for both webinars in the series. To learn more, click here or contact t1dwebinars [at] eocihealth.com (t1dwebinars[at]eocihealth[dot]com).
 

Learning Objectives:
By the end of this program, you will be able to:

1. Summarize the evidence and mechanism of action of emerging T1D therapies, including teplizumab.
2. Compare international and Canadian clinical experience with teplizumab, including patient identification and selection.
3. Describe practical considerations for teplizumab administration, monitoring, and patient management.
4. Apply practical, real-world lessons to support the implementation of teplizumab in the Canadian healthcare setting.

Faculty:
Bruce A. Perkins
MD, MPH, FRCPC
Endocrinologist
Toronto, ON

Kimber Simmons
MD, MS
Pediatric Endocrinologist
Aurora, CO, USA